pentoxifylline has been researched along with Conus Medullaris Syndrome in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enoxaparin and MPA can be used in the treatment of spinal cord injuries." | 1.31 | Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury. ( Akdemir, I; Erol, FS; Gursu, F; Kaplan, M; Kilic, N; Tiftikci, M; Topsakal, C, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topsakal, C | 1 |
| Kilic, N | 1 |
| Erol, FS | 1 |
| Kaplan, M | 1 |
| Akdemir, I | 1 |
| Tiftikci, M | 1 |
| Gursu, F | 1 |
1 other study available for pentoxifylline and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
Topics: Animals; Antioxidants; Enoxaparin; Homocysteine; Lipid Peroxidation; Male; Medroxyprogesterone Aceta | 2002 |